We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
Read MoreHide Full Article
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company to watch right now is Fresenius SE & Co. (FSNUY - Free Report) . FSNUY is currently sporting a Zacks Rank #2 (Buy), as well as an A grade for Value. The stock holds a P/E ratio of 13.26, while its industry has an average P/E of 18.36. FSNUY's Forward P/E has been as high as 13.59 and as low as 9.07, with a median of 11.44, all within the past year.
Value investors also frequently use the P/S ratio. This metric is found by dividing a stock's price with the company's revenue. This is a preferred metric because revenue can't really be manipulated, so sales are often a truer performance indicator. FSNUY has a P/S ratio of 1.05. This compares to its industry's average P/S of 1.43.
Finally, our model also underscores that FSNUY has a P/CF ratio of 15.69. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 32.43. Within the past 12 months, FSNUY's P/CF has been as high as 21.43 and as low as 9.19, with a median of 13.95.
Option Care Health (OPCH - Free Report) may be another strong Medical - Outpatient and Home Healthcare stock to add to your shortlist. OPCH is a Zacks Rank of #2 (Buy) stock with a Value grade of A.
Option Care Health is trading at a forward earnings multiple of 15.09 at the moment, with a PEG ratio of 1.40. This compares to its industry's average P/E of 18.36 and average PEG ratio of 1.32.
OPCH's price-to-earnings ratio has been as high as 25.75 and as low as 14.74, with a median of 18.54, while its PEG ratio has been as high as 2.97 and as low as 1.37, with a median of 1.75, all within the past year.
Additionally, Option Care Health has a P/B ratio of 3.38 while its industry's price-to-book ratio sits at 4.63. For OPCH, this valuation metric has been as high as 4.27, as low as 2.59, with a median of 3.66 over the past year.
These are only a few of the key metrics included in Fresenius SE & Co. and Option Care Health strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, FSNUY and OPCH look like an impressive value stock at the moment.
View the Zacks #1 Rank List
Image: Bigstock
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company to watch right now is Fresenius SE & Co. (FSNUY - Free Report) . FSNUY is currently sporting a Zacks Rank #2 (Buy), as well as an A grade for Value. The stock holds a P/E ratio of 13.26, while its industry has an average P/E of 18.36. FSNUY's Forward P/E has been as high as 13.59 and as low as 9.07, with a median of 11.44, all within the past year.
Value investors also frequently use the P/S ratio. This metric is found by dividing a stock's price with the company's revenue. This is a preferred metric because revenue can't really be manipulated, so sales are often a truer performance indicator. FSNUY has a P/S ratio of 1.05. This compares to its industry's average P/S of 1.43.
Finally, our model also underscores that FSNUY has a P/CF ratio of 15.69. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 32.43. Within the past 12 months, FSNUY's P/CF has been as high as 21.43 and as low as 9.19, with a median of 13.95.
Option Care Health (OPCH - Free Report) may be another strong Medical - Outpatient and Home Healthcare stock to add to your shortlist. OPCH is a Zacks Rank of #2 (Buy) stock with a Value grade of A.
Option Care Health is trading at a forward earnings multiple of 15.09 at the moment, with a PEG ratio of 1.40. This compares to its industry's average P/E of 18.36 and average PEG ratio of 1.32.
OPCH's price-to-earnings ratio has been as high as 25.75 and as low as 14.74, with a median of 18.54, while its PEG ratio has been as high as 2.97 and as low as 1.37, with a median of 1.75, all within the past year.
Additionally, Option Care Health has a P/B ratio of 3.38 while its industry's price-to-book ratio sits at 4.63. For OPCH, this valuation metric has been as high as 4.27, as low as 2.59, with a median of 3.66 over the past year.
These are only a few of the key metrics included in Fresenius SE & Co. and Option Care Health strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, FSNUY and OPCH look like an impressive value stock at the moment.